2015年度業績ー論文
- Tanaka A, Hirohara J, Nakanuma Y, Tsubouchi H, Takikawa H
Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA, J Gastroenterol, 50:675-682, 2015
- Nakamura M, Kondo H, Tanaka A, Komori A, Ito M, Yamamoto K, Ohira H, Zeniya M, Hashimoto E, Honda M, Kaneko S, Ueno Y, Kikuchi K, Shimoda S, Harada K, Arai K, Miyake Y, Abe M, Taniai M, Saibara T, Sakisaka S, Takikawa H, Onji M, Tsubouchi H, Nakanuma Y, Ishibashi H
Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis, Hepatol Res, 45:846- 855, 2015
- Adachi M, Tanaka A, Aiso M, Takamori Y, Takikawa H
The benefit of cystatin C in evaluation of renal function and prediction of survival in patients with cirrhosis, Hepatol Res, 45:1299-1306, 2015
- Fujiwara K, Yokosuka O, Inoue K, Yasui S, Abe R, Oda S, Arata S, Takikawa Y, Ido A, Mochida S, Tsubouchi H, Takikawa H
Distribution of core hospitals for patients with fulminant hepatitis and late onset hepatic failure in Japan, Hepatol Res, 46:10-12, 2015
- Khosroshahi, A ; Wallace, ZS ; Crowe, JL ; Akamizu, T ; Azumi, A ; Carruthers, MN ; Chari, ST ; Della-Torre, E ; Frulloni, L ; Goto, H ; Hart, PA ; Kamisawa, T ; Kawa, S ; Kawano, M ; Kim, MH ; Kodama, Y ; Kubota, K ; Lerch, MM ; Löhr, M ; Masaki, Y ; Matsui, S ; Mimori, T ; Nakamura, S ; Nakazawa, T ; Ohara, H ; Okazaki, K ; Ryu, JH ; Saeki, T ; Schleinitz, N ; Shimatsu, A ; Shimosegawa, T ; Takahashi, H ; Takahira, M ; Tanaka A ; Topazian, M ; Umehara, H ; Webster, GJ ; Witzig, TE ; Yamamoto, M ; Zhang, W ; Chiba, T ; Stone, JH
International Consensus Guidance Statement on the Management and Treatment of IgG4- Related Disease, Arthritis & Rheumatology(Hoboken, N.J.), 67(7):1688-1699, 2015
- Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R
Changing Nomenclature for PBC : From ‘Cirrhosis’ to ‘Cholangitis’, Clin Res Hepatol Gastroenterol, 39(5):e57-e59, 2015
- Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R
Changing nomenclature for PBC : From ‘cirrhosis’ to ‘cholangitis’, J Hepatol, 63(5):1285-1287, 2015
- Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R
Changing Nomenclature for PBC : From ‘Cirrhosis’ to ‘Cholangitis’, Gastroenterology, 149(6): 1627-1629, 2015
- Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R
Changing nomenclature for PBC : from ‘cirrhosis’ to ‘cholangitis’, Gut, 64(11):1671-1672, 2015
- Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R
Changing nomenclature for PBC : From ‘cirrhosis’ to ‘cholangitis’, Hepatology, 62(5):1620-2, 2015
- Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R
Changing nomenclature for PBC : From ‘cirrhosis’ to ‘cholangitis’, Clin Gastroenterol Hepatol, 13(11):1867-1869, 2015
- Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R
Changing nomenclature for PBC : From ‘cirrhosis’ to ‘cholangitis’, Dig Liver Dis, 47(11):924- 926, 2015
- Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R
Changing nomenclature for PBC : From ‘cirrhosis’ to ‘cholangitis’, Am J Gastroenterol, 110(11): 1536-1538, 2015
- Shimoda S, Tanaka A
It is time to change PBC : new nomenclature from “cirrhosis” to “cholangitis”, and upcoming treatment based on unveiling pathology, Hepatol Res, 46(5):407-415, 2015
- Manabe N, Haruma K, Nakajima A, Yamada M, Maruyama Y, Masanori G, Yamamoto T
Characteristics of colonic diverticulitits and factors associated with complications : a Japanese multicenter, retrospective, cross-sectional study, Dis Colon Rectum, 58(12):1174-1181, 2015
- Honda M, Wakita T, Onishi Y, Nunobe S, Miura A, Nishigori T, Kusanagi H, Yamamoto T, Boddy A, Fukuhara S
Development and validation of a disease-specific instrument to measure diet-targeted quality of life for postoperative patients with esophagogastric cancer, Ann Surg Oncol, 22(Suppl 3): S848-S854, 2015
- Abe K, Aoyagi H, Okada N, Saito K, Kuyama Y
Severe oropharyngitis due to herpes simplex virus type 2 infection in an immunocompetent adult, Am J Gastroenterol, 110(8):1140-1140, 2015
- 滝川 一
医学と医療の最前線:薬物性肝障害の診断と治療 , 日内会誌 , 104:991-997, 2015
- 滝川 一
薬物性肝障害 , 成人病と生活習慣病 , 45:633-634, 2015
- 滝川 一(企画・編集)
特集:生活習慣病と消化器疾患 , Modern Physicain, 35:10, 2015
- 滝川 一(司会)、平松直樹、金子周一、柴田 実
座談会:肝疾患診療の新展開 , 日医雑誌 , 144:1385-1395, 2015
- 田中 篤 (Reader’s Indegestion)
「慢性肝疾患における腎機能評価 〜クレアチニンでなくシスタチンを〜」, 肝臓 , 56(7):61:373, 2015
- 田中 篤
「C 型肝炎の最新治療 経口薬をどのように使用すべきか」, 目黒区医師会報 , 233:1, 2015
- 田中 篤
「日本肝臓学会 C 型肝炎治療ガイドライン」, Current Therapy , 33(9):21-25, 2015
- 田中 篤
「C 型肝炎の最新治療 −経口薬をどのように用いるか−」, 東京内科医会会誌 , 31(1):11-15, 2015
- 田中 篤
「自己免疫性肝疾患の最近の進歩」, 日本医師会雑誌 , 144(7):1429-1433, 2015
- 田中 篤
「肝障害をきたす肝炎ウイルス以外の感染症」, 臨床検査 , 59:1388-1392, 2015
- 山本貴嗣
どうする、“胃痛”!? −日常臨床における FD・GERD, 板橋区医師会通報 , 483(3):6-8, 2015
- 山本貴嗣
抗血小板薬と消化管合併症 , CardioVascular Contemporary, 4(2):34-39, 2015
- 山本貴嗣
手指衛生は“泥んこ遊び”後の感覚で , Medical Practice, 32(12):2051-2051, 2015
- Asahina Y, Izumi N, Hiromitsu K, Kurosaki M, Koike K, Suzuki F, Takikawa H, Tanaka A, Tanaka E, Tanaka Y, Tsubouchi H, Hayashi N, Hiramatsu N, Yotsuyanagi H
JSH Guidelines for the Management of Hepatitis C Virus Infection : A 2016 update for genotype 1 and 2, Hepatol Res, 46:129-165, 2016
- Tanaka A, Kikuchi K, Miura R, Miura K, Mikami M, Aiso M, Takamori Y, Takikawa H
Validation of the Japanese version of the Chronic Liver Disease Questionnaire(CLDQ)for the assessment of health-related quality of life in patients with chronic viral hepatitis, Hepatol Res, 46:E45-E50, 2016
- Editors of the Drafting Committee for Hepatitis Management Guidelines
JSH Guidelines for the Management of Hepatitis C Virus Infection : A 2016 update for genotype 1 and 2, Hepatol Res, 46(2):129-165, 2016
- Kimura S
Effect of phase-shifting nutrients on gastric emptying and how it is impacted by rabeprazole in healthy adults, J Clin Physiol, 46:39-44, 2016
- 滝川 一
懇話会:薬物性肝障害の診断と最近の動向 , 日本医事新報 , 4788:46-55, 2016
- 滝川 一
特集:オーダーメイド治療時代の新薬の位置づけと使い方。各種疾患の新しい治療薬。ウイルス肝炎 , 臨牀と研究 , 93:287-293, 2016
- 下田慎治、田中 篤
PBC -“cirrhosis”から“cholangitis”へ , 日本消化器病学会雑誌 , 113(1):36-37, 2016
- 田中 篤
「ウイルス排除後の発癌」, 医薬ジャーナル , 52(1):109-114, 2016
- 田中 篤
「B 型・C 型肝炎の治療戦略 〜最新の肝臓学会ガイドライン〜」, 板橋区医師会通報 , 485:60, 2016
- 田中 篤
「B 型肝炎治療ガイドライン」化学療法の領域 2016 年増刊号「感染症ガイドラインのすべて」, 医薬ジャーナル社 , 32(S-1):41-49, 2016
- 山本貴嗣
身体診察の“ついで”の超音波検査 , Medical Practice, 33(1):135-135, 2016
- 木村 聡
Effect of phase-shifting nutrients on gastric emptying and how it is impacted by rabeprazole in healthy adults, 日本臨床整理学会 , 46(1):39-44, 2016